5 & 6 June 2024
Palexpo, Geneva
Menu Close

Gerresheimer AG and Stevanato Group announce Collaboration

Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry.

  • Two leading companies joined forces to develop a new Ready-To-Use solution platform based on EZ-fill® pre-sterilized platform.
  • Seamless integration into standard fill & finish lines.
  • Significant increase in quality and efficiency.


Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics and Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announce that they have jointly developed a high-end Ready-To-Use (RTU) solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill® technology. This collaboration is projected to help customers gain efficiencies, improve the quality standard, increase speed to market, reduce total cost of ownership (TCO) and help mitigate supply chain risk.

Follow us:

Share this article: